• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Two leading Generali investors could seek new CEO -sources

September 11, 2021 by David Barret Leave a Comment

September 11, 2021

By Gianluca Semeraro and Claudia Cristoferi

MILAN (Reuters) -Two leading Generali investors are ready to push to replace current CEO Philippe Donnet if the top Italian insurer’s board fails to reach an accord to keep him in the job, three sources close to the matter said.

The Trieste-based insurer is due to appoint a new board next spring and speculation over Donnet’s future has mounted in recent months as tensions among shareholders simmer.

In a sign battle lines are being drawn, the two Generali investors, Francesco Gaetano Caltagirone and Leonardo Del Vecchio, on Saturday disclosed a pact to consult over decisions concerning Generali..

Donnet’s reappointment is in the hands of Generali’s board which for the first time can submit its own slate of board candidates after the insurer changed its by-laws last year.

The sources said the two businessmen, who struck the pact over a combined 10.95% stake, are ready to file their own list of board nominees. The list would not include the current CEO though he is willing to run for another mandate, they said.

Donnet is already working on a new business plan for Generali due in December after steering the company through the COVID-19 crisis and keeping it on track to fully meet goals under the current plan through to end-2021.

Donnet currently enjoys the backing of Alberto Nagel, the CEO of Milanese bank Mediobanca, which is Generali’s top investor with a 12.9% stake, as well as many board members at the insurer.

Del Vecchio and Caltagirone are also, respectively, the first- and second-biggest investor in Mediobanca.

Over the past year, however, both Caltagirone, whose businesses span construction to publishing, and Del Vecchio, the founder of Ray-Ban owner Luxottica, have been critical of Donnet’s strategy which they deem too cautious in seeking merger and acquisition opportunities.

According to one of the sources, the two businessmen could also propose a new chairman with a well-established international profile to oversee Generali’s growth strategies.

A compromise among shareholders is still possible, another of the sources said, and one solution could be the appointment of a managing director backed by both Del Vecchio and Caltagirone who would work alongside Donnet.

However, positions are still far apart, the sources said, ahead of a key meeting on Sept. 27 when Generali’s board will kick off proceedings to submit its own list of nominees.

Before that, in an apparent attempt to find common ground, Generali non-executive board members will meet on Sept. 14, a fourth source said. Donnet will not attend the meeting as he is an executive member, the source added.

(Reporting by Claudia Cristoferi and Gianluca Semeraro, editing by Valentina Za, Ros Russell and Christina Fincher)

Source Link Two leading Generali investors could seek new CEO -sources

David Barret
David Barret

Related posts:

  1. What 377 Y Combinator pitches will teach you about startups
  2. Tennis-Fearless teenagers and hungry qualifiers light up U.S. Open
  3. South Africa’s former President Zuma placed on medical parole
  4. Tennis-Qualifier Van de Zandschulp tames Argentine battler to reach quarters

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • What Alternatives Are There To The Big Bang Model?
  • Magnetic Flip Seen Around First Photographed Black Hole Pushes “Models To The Limit”
  • Something Out Of Nothing: New Approach Mimics Matter Creation Using Superfluid Helium
  • Surströmming: Why Sweden’s Stinky Fermented Fish Smells So Bad (But People Still Eat It)
  • First-Ever Recording Of Black Hole Recoil Captured During Merger – And You Can Listen To It
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version